Prof. Mats Jerkeman
Medical Oncologist
- Lund University
Sweden
Sweden Dr Mats Jerkeman, MD, completed his training in Clinical Oncology at Lund University, Sweden, where he is currently Professor in Clinical Oncology, and Head of Division of Oncology. His research focuses on the development of clinical trials in lymphoma, and in clinical epidemiology. He is Chairman of the Nordic Lymphoma Group, and Editor of the ESMO Guidelines of Lymphoma.
Prof. Mats Jerkeman has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Abbvie, AstraZeneca, Celgene, Gilead, Incyte, Janssen and Roche.
Programmes developed by Prof. Mats Jerkeman
Hemato-oncology
Follicular Lymphoma Review Paper Published in The Oncologist
A review paper ‘Follicular lymphoma: recent and emerging therapies, treatment strategies, and remaining unmet needs’ authored by LYMPHOMA CONNECT members
Experts
Prof. Alexey V Danilov, Assoc. Prof. Loretta Nastoupil, Dr Matthew J. Matasar, Prof. Daniel Perksy, Dr Massimo Magagnoli, Assoc. Prof. Stefan K Barta, Prof. Paul M Barr, Assoc. Prof. Tycel Phillips, Dr Jessica Okosun, Prof. Mats Jerkeman, Prof. Stefano Luminari, Dr Brian Hill-
Downloadable
Resources -
MIN
-
Sep 2021
Downloadable 
MIN
Sep 2021 
